Overview Fundamentals API Earnings EOD API Sample Code Pricing

Neurobo Pharmaceuticals Inc (NRBO NASDAQ) stock market data APIs

$4.68 -0.32(-6.4%) as of July 12, 2024
Price chart is built with Anychart

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Neurobo Pharmaceuticals Inc Financial Data Overview

49 975 K
9 995 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NRBO',
Type: 'Common Stock',
Name: 'Neurobo Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG009YPPXR8',
CIK: '1638287',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2016-08-05',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Neurobo Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -20 238 000
  • Earnings Per Share 0.3
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Neurobo Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -3.63

Get Neurobo Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?